Related Experiment Videos
The third molecule associated with interleukin 2 receptor alpha and beta chain.
1First Division of Internal Medicine, Faculty of Medicine, Kyoto University, Japan.
Biochemical and Biophysical Research Communications
|May 15, 1992
Summary
Researchers identified a novel IL-2 binding protein (p65) distinct from the beta chain. This protein, along with the beta chain, may mediate intermediate-affinity Interleukin 2 (IL-2) binding.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- The high-affinity Interleukin 2 (IL-2) receptor is crucial for T cell function.
- Affinity cross-linking studies reveal alpha (Tac) and beta chains involved in IL-2 binding.
Purpose of the Study:
- To investigate the composition of IL-2 binding complexes.
- To identify novel IL-2 binding proteins beyond the known alpha and beta chains.
Main Methods:
- Affinity cross-linking of Interleukin 2 (IL-2) to human T cells.
- Immunoprecipitation using anti-Tac and anti-beta chain antibodies.
- Analysis of protein bands via SDS-PAGE.
Main Results:
- Identified triplet bands in IL-2 receptor cross-linking: 70 kDa alpha chain-IL-2 and a 90/80 kDa doublet.
- Observed cell lines expressing alpha and beta chains but lacking the lower 80 kDa doublet band.
- Immunoprecipitation with anti-beta chain antibody detected the upper 90 kDa band but not the lower 80 kDa band.
Conclusions:
- The lower 80 kDa band represents an unknown IL-2 binding protein (p65), distinct from the beta chain.
- This novel protein (p65) likely participates with the beta chain in intermediate-affinity IL-2 binding.
- Further research is warranted to elucidate the precise role of p65 in IL-2 receptor signaling.